Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
29.2%
% of PPH's 27 holdings also in PJP
31.8%
% of PJP's 22 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.3% | 6.0% | 6.0% |
|
ELI LILLY & CO | 12.5% | 6.0% | 6.0% |
|
MERCK & CO. INC. | 5.7% | 5.6% | 5.6% |
|
ABBVIE INC | 5.5% | 6.2% | 5.5% |
|
PFIZER INC | 4.9% | 5.9% | 4.9% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to PJP
 |
NOVO-NORDISK A/S-SPONS ADR | 9.3% |
|
ELI LILLY & CO | 6.6% |
 |
NOVARTIS AG-ADR | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
ZOETIS INC | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% |
|
MCKESSON CORP | 4.5% |
|
AMERISOURCEBERGEN CORP | 4.4% |
PPH Underweight Relative to PJP
|
AMGEN INC | -6.2% |
|
REGENERON PHARMACEUTICALS | -6.1% |
|
ABBOTT LABORATORIES | -5.6% |
|
GERON CORP | -4.8% |
|
UNITED THERAPEUTICS CORP | -4.3% |
|
LIGAND PHARMACEUTICALS-CL B | -4.0% |
|
GILEAD SCIENCES INC | -4.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.9% |
|
SUPERNUS PHARMACEUTICALS INC | -3.9% |
|
INNOVIVA, INC. | -3.9% |